These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 17465957
1. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Ghevaert C, Campbell K, Walton J, Smith GA, Allen D, Williamson LM, Ouwehand WH, Ranasinghe E. Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957 [Abstract] [Full Text] [Related]
3. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Birchall JE, Murphy MF, Kaplan C, Kroll H, European Fetomaternal Alloimmune Thrombocytopenia Study Group. Br J Haematol; 2003 Jul; 122(2):275-88. PubMed ID: 12846898 [Abstract] [Full Text] [Related]
4. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Murphy MF, Metcalfe P, Waters AH, Ord J, Hambley H, Nicolaides K. Blood; 1993 Apr 15; 81(8):2174-9. PubMed ID: 8471776 [Abstract] [Full Text] [Related]
5. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Kaplan C, Porcelijn L, Vanlieferinghen P, Julien E, Bianchi F, Martageix C, Bertrand G, Jallu V. Transfusion; 2005 Nov 15; 45(11):1799-803. PubMed ID: 16271107 [Abstract] [Full Text] [Related]
6. Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies. Murphy MF, Waters AH, Doughty HA, Hambley H, Mibashan RS, Nicolaides K, Rodeck CH. Transfus Med; 1994 Dec 15; 4(4):281-92. PubMed ID: 7889140 [Abstract] [Full Text] [Related]
7. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia. de Vos TW, Porcelijn L, Hofstede-van Egmond S, Pajkrt E, Oepkes D, Lopriore E, van der Schoot CE, Winkelhorst D, de Haas M. Br J Haematol; 2021 Nov 15; 195(4):595-603. PubMed ID: 34402048 [Abstract] [Full Text] [Related]
8. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Ghevaert C, Campbell K, Stafford P, Metcalfe P, Casbard A, Smith GA, Allen D, Ranasinghe E, Williamson LM, Ouwehand WH. Transfusion; 2007 Jul 15; 47(7):1296-305. PubMed ID: 17581167 [Abstract] [Full Text] [Related]
9. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Sainio S, Teramo K, Kekomäki R. Transfus Med; 1999 Dec 15; 9(4):321-30. PubMed ID: 10583886 [Abstract] [Full Text] [Related]
10. The management of alloimmune neonatal thrombocytopenia. Blanchette VS, Johnson J, Rand M. Baillieres Best Pract Res Clin Haematol; 2000 Sep 15; 13(3):365-90. PubMed ID: 11030040 [Abstract] [Full Text] [Related]
11. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH. Blood; 1998 Oct 01; 92(7):2280-7. PubMed ID: 9746765 [Abstract] [Full Text] [Related]
12. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele. Smith GA, Rankin A, Riddle C, Cheetham-Wilkinson C, Ranasinghe E, Ouwehand WH, Watkins NA. Vox Sang; 2007 Nov 01; 93(4):325-30. PubMed ID: 18070277 [Abstract] [Full Text] [Related]
13. HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases. Rousseau J, Goldman M, David M. Transfusion; 2004 Jun 01; 44(6):844-8. PubMed ID: 15157249 [Abstract] [Full Text] [Related]
14. The natural history of maternal immunization against foetal platelet alloantigens. Ohto H, Miura S, Ariga H, Ishii T, Fujimori K, Morita S, Collaborative Study Group. Transfus Med; 2004 Dec 01; 14(6):399-408. PubMed ID: 15569234 [Abstract] [Full Text] [Related]
15. Severe fetomaternal alloimmune thrombocytopenia presenting with fetal hydrocephalus. Murphy MF, Hambley H, Nicolaides K, Waters AH. Prenat Diagn; 1996 Dec 01; 16(12):1152-5. PubMed ID: 8994253 [Abstract] [Full Text] [Related]
16. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Kaplan C, Morel-Kopp MC, Kroll H, Kiefel V, Schlegel N, Chesnel N, Mueller-Eckhardt C. Br J Haematol; 1991 Jul 01; 78(3):425-9. PubMed ID: 1873226 [Abstract] [Full Text] [Related]
17. Incidental diagnosis and tempestive therapy in a case of neonatal alloimmune thrombocytopenia due to anti-HPA-5b. Zuppa AA, Cota F, De Luca D, Visintini F, De Turris PL, Tortorolo G. Pediatr Hematol Oncol; 2002 Dec 01; 19(8):587-91. PubMed ID: 12487835 [Abstract] [Full Text] [Related]
18. [Neonatal alloimmune thrombocytopenia]. Schechter Y, Zeides I, Shalev E, Sharon R. Harefuah; 1994 Dec 15; 127(12):505-8, 576. PubMed ID: 7813921 [Abstract] [Full Text] [Related]
19. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Spencer JA, Burrows RF. Aust N Z J Obstet Gynaecol; 2001 Feb 15; 41(1):45-55. PubMed ID: 11284646 [Abstract] [Full Text] [Related]
20. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study. Refsum E, Håkansson S, Mörtberg A, Wikman A, Westgren M. Transfusion; 2018 Jan 15; 58(1):223-231. PubMed ID: 29119564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]